OtherErratum

Erratum to Simultaneous inhibition of PI3Ka and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, Chunhao Yang, Cun Tan, Bobo Wang, Yiming Sun, Xi Zhang, Yinglei Gao, Jian Ding and Linghua Meng
Cancer Biology & Medicine November 2019, 16 (4) 836; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0401

In the published Figure 11, errors appeared in Figure 1B on page 69. In Figure 1B, bands for p-Akt S473, Akt, and Actin in H1355 cells were mistakenly placed. Here, we have updated Figure 1B to correct the mistake above. The errors do not impact the conclusions of this article. We apologize for the errors and for any confusion it may have caused.

1B
1B

NSCLC cells were treated with CYH33 at the indicated concentrations for 1 h. Cell lysates were subjected to Western blot with the indicated antibodies.

  • Received November 25, 2019.
  • Accepted November 28, 2019.
https://creativecommons.org/licenses/by/4.0/

This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

References

  1. 1.↵
    2. Wang YX,
    3. Li X,
    4. Liu XL,
    5. Chen Y,
    6. Yang CH,
    7. Tan C, et al.
    Simultaneous inhibition of pi3k alpha and cdk4/6 synergistically suppresses kras-mutated non-small cell lung cancer. Cancer Biol Med 2019; 16: 66–83.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section